Obesidad como factor implicado en la gravedad de la infección por SARS-CoV-2
Obesity as a factor involved in the severity of SARS-CoV-2 infectionBarra lateral del artículo
Contenido principal del artículo
Las personas obesas enfrentan mayores complicaciones al contraer SARS-CoV-2 debido a su estado proinflamatorio crónico y respuesta inmune reducida, relacionados con el exceso de tejido adiposo. La interacción del virus con los receptores ACE2 y la retención de lípidos ectópicos renales son aspectos clave en este contexto. Objetivo. Analizar las características específicas de la obesidad que aumentan la susceptibilidad a síntomas graves de COVID-19, a partir de artículos publicados entre 2020 y 2022, y promover futuras investigaciones. Metodología. Se realizó una revisión sistemática de artículos originales entre 2020 y 2022 utilizando términos clave y operadores booleanos en bases de datos como PubMed, Scopus, ProQuest, etc. Se excluyeron estudios no originales para obtener investigaciones más específicas. Resultados. De 180 artículos encontrados, 42 fueron seleccionados. Entre estos, se destacó que pacientes obesos, especialmente hombres de edad avanzada, presentaron severas complicaciones. Sin embargo, jóvenes con obesidad severa y personas con bajo peso también mostraron mayor riesgo de mortalidad. La disminución de la función pulmonar, bajos niveles de vitamina D, y la alteración de ACE2 fueron implicados en la gravedad de la infección. La hiperglucemia asociada a la obesidad aumentó el riesgo de ingreso a UCI y ventilación mecánica, mientras que la resistencia a la insulina empeoró el pronóstico. Conclusión. La obesidad emerge como un factor de riesgo importante para la gravedad y mortalidad por COVID-19, señalando la necesidad de una atención específica para este grupo de pacientes y la continuación de investigaciones en el área.
Obese individuals face greater complications in contracting SARS-CoV-2 due to their chronic proinflammatory state and reduced immune response, related to excess adipose tissue. Virus interaction with ACE2 receptors and renal ectopic lipid retention are key issues in this context. Objective. To analyze the specific features of obesity that increase susceptibility to severe COVID-19 symptoms, from articles published between 2020 and 2022, and to promote future research. Methodology. A systematic review of original articles between 2020 and 2022 was conducted using key terms and Boolean operators in databases such as PubMed, Scopus, ProQuest, etc. Non-original studies were excluded to obtain more specific research. Results. Of 180 articles found, 42 were selected. Among these, it was highlighted that obese patients, especially elderly men, presented severe complications. However, young people with severe obesity and people with low weight also showed a higher risk of mortality. Decreased lung function, low vitamin D levels, and altered ACE2 were implicated in the severity of infection. Obesity-associated hyperglycemia increased the risk of ICU admission and mechanical ventilation, while insulin resistance worsened prognosis. Conclusion. Obesity emerges as an important risk factor for severity and mortality due to COVID-19, pointing to the need for specific attention to this group of patients and further research in the area.
Descargas
Detalles del artículo
Ena J, Wenzel R. Un nuevo coronavirus emerge. Revista Clínica Española. 2023;220(2):115-6. Disponible en: https://doi.org/10.1016/j.rce.2020.01.001
Nguyen P, Nguyen B, Ngo T, Nguyen H, Phan H. Correlations between Excessive Body Mass Index, Body Perception, Physical Activity, and Respiratory Functions among Youths in an Urban Setting of Vietnam. BioMed Research International. 24 de agosto de 2020;2020:e9627605. https://doi.org/10.1155/2020/9627605
Bello-Chavolla O, Bahena-López J, Antonio-Villa N, Vargas-Vázquez A, González-Díaz A, Márquez-Salinas A. Predicting Mortality Due to SARS-CoV-2: A Mechanistic Score Relating Obesity and Diabetes to COVID-19 Outcomes in Mexico. The Journal of Clinical Endocrinology & Metabolism. 2020;105(8):2752-61. https://doi.org/10.1210/clinem/dgaa346
Petersen A, Bressem K, Albrecht J, Thieß HM, Vahldiek J, Hamm B. The role of visceral adiposity in the severity of COVID-19: Highlights from a unicenter cross-sectional pilot study in Germany. Metabolism. 2020; 110:154317. https://doi.org/10.1016/j.metabol.2020.154317
Lim S. Association between obesity and COVID-19. J Korean Med Assoc. 2022;65(7):423-9. https://doi.org/10.5124/jkma.2022.65.7.423
Pérez-Cruz E, Castanon-Gonzalez J, Ortiz-Gutierrez S, Garduno-Lopez J, Luna-Camacho Y. Impact of obesity and diabetes mellitus in critically ill patients with SARS-CoV-2. Obes Res Clin Pract. 2021;15(4):402-5. https://doi.org/10.1016/j.orcp.2021.05.001
Li S, Cao Z, Yang H, Zhang Y, Xu F, Wang Y. Metabolic Healthy Obesity, Vitamin D Status, and Risk of COVID-19. Aging and disease. 2021;12(1):61-71. https://doi.org/10.14336/AD.2020.1108
Shang L, Wang L, Zhou F, Li J, Liu Y, Yang S. Long-term effects of obesity on COVID-19 patients discharged from hospital. IMMUN INFLAMM DIS. 2021;9(4):1678-85. https://doi.org/10.1002/iid3.522
Al Heialy S, Hachim M, Senok A, Gaudet M, Abou Tayoun A, Hamoudi R. Regulation of Angiotensin- Converting Enzyme 2 in Obesity: Implications for COVID-19. Front Physiol 2020;11 (1). https://www.frontiersin.org/articles/10.3389/fphys.2020.555039. Doi: 10.3389/fphys.2020.555039
Che YY, Hong H, Lei YT, Zou J, Yang YY, He LY, et al. ACE2 deficiency exacerbates obesity-related glomerulopathy through its role in regulating lipid metabolism. Cell Death Discovery. 2022;8(1). https://www.proquest.com/docview/2719621042/abstract/30895B4BC8834E57PQ/1. Doi: 10.1038/s41420-022-01191-2
Macaya F, Espejo Paeres C, Valls A, Fernández-Ortiz A, González Del Castillo J, Martín-Sánchez FJ, et al. Interaction between age and vitamin D deficiency in severe COVID-19 infection. Nutr Hosp. 21 de octubre de 2020;37(5):1039-42.https://doi.org/10.20960/nh.03193
Li Y, Tong CH, Bare LA, Devlin JJ. Assessment of the Association of Vitamin D Level With SARS-CoV-2 Seropositivity Among Working-Age Adults. JAMA Network Open. 2021;4(5):e2111634. https://doi.org/10.1001/jamanetworkopen.2021.11634
Smith S, Boppana A, Traupman J, Unson E, Maddock D, Chao K. Impaired glucose metabolism in patients with diabetes, prediabetes and obesity is associated with severe Covid?19. Journal of Medical Virology. 2020; https://www.proquest.com/docview/2417746010/abstract/D8D99BE4D8964861PQ/9. Doi: 10.1002/jmv.26227
Mayneris-Perxachs J, Francesca Russo M, Ramos R, de Hollanda A, Armengou Arxe A, Rottoli M. Blood Hemoglobin Substantially Modulates the Impact of Gender, Morbid Obesity, and Hyperglycemia on COVID-19 Death Risk: A Multicenter Study in Italy and Spain. Front Endocrinol. 2020;21(9):e13083. https://doi.org/10.1111/obr.13083
Silva R, Jara C, Sidarta-Oliveira D, Velloso L, Velander W, Araújo E. Downregulation of the Protein C Signaling System Is Associated with COVID-19 Hypercoagulability-A Single-Cell Transcriptomics Analysis. Viruses. 2022;14(12). https://doi.org/10.3390/v14122753
Zahid M, Leung V, Nayudu S, Galiveeti S, Mantri N, Sun H. Role of body mass index in outcomes of patients hospitalized with COVID-19 illness. Obesity Science and Practice. 2022;8(6):748-56. https://doi.org/10.1002/osp4.607
Hou P, Pi Y, Jiao Z, Tian X, Hu W, Zhang Y, et al. Association of Body Composition with Pulmonary Function in Ningxia: The China Northwest Cohort. Diabetes Metab Syndr Obes. 2022;15:3243-54. https://doi.org/10.2147/DMSO.S383098
Alqahtani F, Aleanizy F, Mohamed A, Al-Maflehi N, Alrfaei B, Alkhudair N.Association Between Obesity and COVID-19 Disease Severity in Saudi Population. Diabetes Metab Syndr Obes. 2022;15:1527-35. https://doi.org/10.2147/dmso.s365491
Motaib I, Zbiri S, Elamari S, Dini N, Chadli A, El Kettani C. Obesity and Disease Severity Among Patients With COVID-19. Cureus J Med Sci . 2021;13(2):e13165. https://doi.org/10.7759/cureus.13165
Fericean R, Citu C, nueva E a sitio externo E enlace se abrirá en una ventana, Manolescu D, Rosca O, Bratosin F, et al. Characterization and Outcomes of SARS-CoV-2 Infection in Overweight and Obese Patients: A Dynamic Comparison of COVID-19 Pandemic Waves. Journal of Clinical Medicine. 2022;11(10). Doi: 10.3390/jcm11102916
Albarrán?Sánchez A, nueva E a sitio externo E enlace se abrirá en una ventana, Ramírez?Rentería C, nueva E a sitio externo E enlace se abrirá en una ventana, Anda?Garay JC, nueva E a sitio externo E enlace se abrirá en una ventana, et al. Differences in mortality rate among patients hospitalized with severe COVID?19 according to their body mass index. Obesity Science & Practice. 2022;8(4):423-32. https://doi.org/10.1002/osp4.584
Avendaño L, Blacio C, Calderón A, Cueva M. Caracterización clínica y de gravedad de adultos con COVID-19 hospitalizados. BMSA. 2022;62(2):218-26. http://iaes.edu.ve/iaespro/ojs/index.php/bmsa/article/view/464 Doi: 10.52808/bmsa.7e6.622.012
Vera-Zertuche J, Mancilla-Galindo J, Tlalpa-Prisco M, Aguilar-Alonso P, Aguirre-García M, Segura-Badilla O. Obesity is a strong risk factor for short-term mortality and adverse outcomes in Mexican patients with COVID-19: a national observational study. Epidemiology and Infection;149. Doi: 10.1017/S0950268821001023
Youri K, Sergei T, Ashot A, Nikolenko VN, Leonid G, Sinelnikov MY, et al. Analysis of Risk Factors in COVID-19 Adult Mortality in Russia. Journal of Primary Care & Community Health. 2021;12. 10.1177/21501327211008050
Lee H, Chubachi S, Namkoong H, Tanaka H, Otake S, Nakagawara K. Effects of mild obesity on outcomes in Japanese patients with COVID-19: a nationwide consortium to investigate COVID-19 host genetics. Nutrition and Diabetes. 2022;12(1). Doi: https://doi.org/10.3389/fimmu.2021.675018
Paravidino V, Leite T, Mediano F, Sichieri R, Azevedo e Silva G, Cravo V. Association between obesity and COVID-19 mortality and length of stay in intensive care unit patients in Brazil: a retrospective cohort study. Scientific Reports. 2022;12(1). https://pubmed.ncbi.nlm.nih.gov/35962010/ Doi: 10.1038/s41598-022-17197-w
Wu X, Li C, Chen S, Zhang X, Wang F, Shi T. Association of body mass index with severity and mortality of COVID-19 pneumonia: a two-center, retrospective cohort study from Wuhan, China. Aging. 2021;13(6):7767-80. https://www.aging-us.com/article/202813/text Doi: 10.18632/aging.202813
Dana R, Bannay A, Bourst P, Ziegler C, Losser M, Gibot S. Obesity and mortality in critically ill COVID-19 patients with respiratory failure. Int J Obes. 2021;45(9):2028-37. https://www.nature.com/articles/s41366-021-00872-9 Doi: 10.1038/s41366-021-00872-9
Lemyze M, Courageux N, Maladobry T, Arumadura C, Pauquet P, Orfi A. Implications of Obesity for the Management of Severe Coronavirus Disease 2019 Pneumonia. Crit Care Med. septiembre de 2020;48(9):e761-7. Doi: 10.1097/CCM.0000000000004455
Martineau A, Jolliffe D, Greenberg L, Aloia J, Bergman P, Dubnov-Raz G. Vitamin D supplementation to prevent acute respiratory infections: individual participant data meta-analysis. Health Technol Assess. enero de 2019;23(2). https://pubmed.ncbi.nlm.nih.gov/30675873/. Doi: 10.3310/hta23020
Nicolau J, Ayala L, Sanchís P, Rodríguez I, Romano A, Dotres K. The coexistence of low albumin levels and obesity worsens clinical outcomes among subjects admitted for sars-cov-2 infection. Clin Nutr ESPEN. 2021;46:434-8. Doi: https://doi.org/10.1016/j.clnesp.2021.09.722
Guo S, Bowyer G, Ferdinand J, Maes M, Tuong Z, Gillman E. Obesity Is Associated with Attenuated Tissue Immunity in COVID-19. Am J Respir Crit Care Med. 2023;207(5):566-76. Doi: https://doi.org/10.1164/rccm.202204-0751OC
Xu L, Li D, Zhu Y, Cai S, Liang X, Tang Y. Swertiamarin supplementation prevents obesity-related chronic inflammation and insulin resistance in mice fed a high-fat diet. Adipocyte. 2021;10(1):160-73. Doi: 10.1080/21623945.2021.1906510
Jiang J, Cai X, Pan Y, Du X, Zhu H, Yang X, et al. Relationship of obesity to adipose tissue insulin resistance. BMJ Open Diabetes Research and Care. 2020;8(1):e000741. https://drc.bmj.com/content/8/1/e000741
Rychter A, Zawada A, Ratajczak A, Dobrowolska A, Krela?Ka?mierczak I. Should patients with obesity be more afraid of COVID?19? Obes Rev [Internet]. septiembre de 2020;21(9):e13083. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7362042/ Doi: 10.1111/obr.13083
Kumar R, Mal K, Razaq M, Magsi M, Memon M, Memon S. Association of Leptin With Obesity and Insulin Resistance. Cureus. 2020;12(12). https://www.cureus.com/articles/47751-association-of-leptin-with-obesity-and-insulin-resistance
Shin J, Toyoda S, Nishitani S, Onodera T, Fukuda S, Kita S. SARS-CoV-2 infection impairs the insulin/IGF signaling pathway in the lung, liver, adipose tissue, and pancreatic cells via IRF1. Metabolism. 2022;133. https://www.metabolismjournal.com/article/S0026-0495(22)00114-7/fulltext
Li Q, Wang Q, Xu W, Ma Y, Wang Q, Eatman D, et al. C-Reactive Protein Causes Adult-Onset Obesity Through Chronic Inflammatory Mechanism. Front Cell Dev Biol 2020;8. Doi: 10.3389/fcell.2020.00018
Maldonado-Cabrera A, Angulo-Molina A, Haque U, Velazquez C, Álvarez-Villaseñor AS, Santacruz-Gómez KJ, et al. Acute Inflammatory Mediators in Young Adult Patients with COVID-19 in Mexico. Pathogens. 2021;10(8):1056. https://www.mdpi.com/2076-0817/10/8/1056
Wijngaarden L, van der Harst E, Klaassen R, Dunkelgrun M, Kuijper T, Klepper M. Effects of Morbid Obesity and Metabolic Syndrome on the Composition of Circulating Immune Subsets. Front Immunol. 2021; 12:675018. Doi: 10.3389/fimmu.2021.675018
Lubrano R, nueva E a sitio externo E enlace se abrirá en una ventana, Bloise S, nueva E a sitio externo E enlace se abrirá en una ventana, Sanseviero M, nueva E a sitio externo E enlace se abrirá en una ventana, et al. Assessment of Cardio-Respiratory Function in Overweight and Obese Children Wearing Face Masks during the COVID-19 Pandemic. Children. 2022;9(7). Doi: 10.3390/children9071053
Ayalon I, Bodilly L, Kaplan J. The Impact of Obesity on Critical Illnesses. 2021;56(5):691. https://journals.lww.com/shockjournal/Fulltext/2021/11000/The_Impact_of_Obesity_on_Critical_Illnesses.6.aspx Doi: 10.1097/SHK.0000000000001821